MedPath

Clinical trial to compare effectiveness of 5% IMIQUIMOD CREAM versus 10% KOH solution in treatment of molluscum contagiosum in pediatric age group.

Not Applicable
Conditions
Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Registration Number
CTRI/2024/04/065129
Lead Sponsor
Bangalore Medical College and Research Institue
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.patient of either gender 0-18yrs

2.Patients willing to give informed consent.

3.Patients willing for follow up.

4.All clinically diagnosed cases of Molluscum contagiosum, who have not taken any treatment in the past 2 weeks.

Exclusion Criteria

Patients not willing to give informed consent.

Patients more than 18years of age.

Patients with secondary infection and hypersensitivity to imiquimod.

Patients already on molluscum contagiosum treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the efficacy of 10% koh solution versus 5% imiquimod cream in treating molluscum contagiosum.Timepoint: Lesions number and size will be assessed every 2 weekly till 8 weeks
Secondary Outcome Measures
NameTimeMethod
Side effects of each group comparison. <br/ ><br>Timepoint: Assessed every 2 weeks
© Copyright 2025. All Rights Reserved by MedPath